Month: November 2014

China’s State Council issues the “Energy Development Strategy Action Plan 2014 – 2020”

The plan contains 5 strategic tasks: 1. enhance independent energy supplies (clean use of coal, increase in domestic oil and natural gas production, provide emergency reserve), 2. revolutionize and lower energy consumption, 3. optimize energy structure (less coal, more natural gas and nuclear energy, more renewables), 4. expand international cooperation and participate in global energy […]

„Nature Index 2014“ finds increasing role of CAS and other Chinese institutions in global research.

Nature has ranked CAS as No. 6, shortly behand the Max-Planck-Society, in global scientific output, as measured by the number of publications in 68 Nature-associated magazines. CAS in 2013 published 165 papers in these magazines, as compared to Harvard University with 387 papers. Nine Chinese institutions were placed in the top 200, up from three […]

China’s major center for microbial culture collections hosts > 46.000 patent strains

According to an interview of deputy director Lijun XIONG of CGMCC (China General Microbiological Culture Collection Center), the Center, located at the CAS Institute of Microbiology in Beijing and founded in 1979, a signatory of the Budapest Treaty in 1995, also hosts a gene library for about 10.000 strains. Stocks are usually preservied in liquid […]

Anke Biotechnology licenses acidic fibroblast growth factor (aFGF) from Whenzou University

Anhui’s Anke Biotechnology Co. has already licensed KGF-2 (lyophilized recombinant human keratinocyte growth factor-2). The licensing of aFGF is to develop technology for diabetic foot treatment. China has 114 million diabetic patients, over 30% of all patients have skin lesions, one of the most typical and most harmful symptoms of diabetic foot. 3% to 6% […]

Scroll to top